Evidence map›Paper›PMID 33763041›Full record

ArticleFrontiers in microbiology2021

Yanqin Huang, Tiffany Wu, Omar Perez, Amisha P Rana, Liang Chen, Barry N Kreiswirth, Michael J Satlin, Zackery P Bulman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Ceftazidime-avibactam based combinations against carbapenemase producingComputational and structural biotechnology journal · 2022
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yanqin HuangDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.
Tiffany WuDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.
Omar PerezDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.
Amisha P RanaDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.
Liang ChenCenter for Discover and Innovation, Hackensack Meridian Health, Nutley, NJ, United States.
Barry N KreiswirthCenter for Discover and Innovation, Hackensack Meridian Health, Nutley, NJ, United States.
Michael J SatlinDepartment of Medicine, Weill Cornell Medicine, New York, NY, United States.
Zackery P BulmanDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.
University of Illinois Chicago · USCenter for Discovery · USCornell University · US

Funding

The molecular basis of the epidemic blaKPC gene KlebsiellaR01AI090155 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KREISWIRTH, BARRY NEAL · 2011 to 2021
$7.2M
Institutional Career DevelopmentKL2TR002002 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PHILLIPS, SHANE A · 2016 to 2024
$6.8M
Novel Strategies for Antibiotic Combinations to Combat Gram-negative SuperbugsR01AI148560 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BULITTA, JURGEN BERND, TSUJI, BRIAN · 2020 to 2024
$3.9M
NCATS NIH HHS KL2 TR002002NIAID NIH HHS R01 AI090155NIAID NIH HHS R01 AI148560
6 · The paper itself

Abstract

Ceftazidime/avibactam is an important treatment option for infections caused by

Indexed as

carbapenemaseceftazidime/avibactamKlebsiella pneumoniaesynergytime kill assay and antibacterial activity

Identifiers

PMID33763041
PMCPMC7982837
OpenAlexW3135228551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.